3.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie
Is Oramed Pharmaceuticals Inc. stock a buy in volatile markets2025 Retail Activity & Daily Volume Surge Signals - ulpravda.ru
Will Oramed Pharmaceuticals Inc. stock outperform value stocks2025 Key Lessons & Intraday High Probability Alerts - ulpravda.ru
Oramed inks deal with Medicox for oral insulin in South Korea - The Pharma Letter
MSN Money - MSN
Oramed Pharmaceuticals Inc. Approves Cash Dividend Payable on January 26, 2026 - MarketScreener
Oramed stock rises after receiving $18 million payment from Scilex By Investing.com - Investing.com South Africa
Oramed receives $18 million payment from Scilex, declares dividend By Investing.com - Investing.com Nigeria
Oramed Pharm Announces Dividend After Scilex Payment Gain - TipRanks
Oramed receives $18 million payment from Scilex, declares dividend - Investing.com
Oramed Pharmaceuticals Inc Receives $18 Million Payment and Approves Dividend - TradingView — Track All Markets
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments - PR Newswire
What analysts say about Oramed Pharmaceuticals Inc stockLow Beta Stocks & Breakthrough Profit Margins - earlytimes.in
Oramed Pharmaceuticals director Leonard Sank to resign after 18 years By Investing.com - Investing.com Nigeria
Oramed Pharmaceuticals director Leonard Sank to resign after 18 years - Investing.com
Oramed Pharm Announces Long-Tenured Director’s Upcoming Resignation - TipRanks
Oramed Pharmaceuticals completes $28.5 million warrant repurchase by Scilex - Investing.com Nigeria
Oramed Pharm Completes Warrant Sale, Boosting Liquidity - TipRanks
Oramed Pharmaceuticals Completes Warrant Repurchase with Scilex - TradingView — Track All Markets
Scilex Holding completes $27 million repurchase of warrants from Oramed By Investing.com - Investing.com South Africa
Scilex Holding completes $27 million repurchase of warrants from Oramed - Investing.com India
Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback - Seeking Alpha
Analyst Downgrade: Will Oramed Pharmaceuticals Inc stock outperform value stocksRate Hike & Daily Market Momentum Tracking - moha.gov.vn
Total debt per share of Oramed Pharmaceuticals Incorporated – TRADEGATE:OJU1 - TradingView — Track All Markets
Is Oramed Pharmaceuticals Inc. (OJU1) stock suitable for passive index fundsQuarterly Profit Review & Reliable Volume Spike Alerts - Улправда
Aug Swings: Will Oramed Pharmaceuticals Inc stock outperform value stocksWeekly Stock Analysis & Expert Verified Stock Movement Alerts - moha.gov.vn
Why Oramed Pharmaceuticals Inc. stock could outperform in 2025Recession Risk & Daily Technical Forecast Reports - Улправда
Oramed Pharmaceuticals (FRA:OJU1) EV-to-OCF : 1.41 (As of Dec. 19, 2025) - GuruFocus
Will Oramed Pharmaceuticals Inc. stock maintain growth storyQuarterly Trade Review & Target Return Focused Picks - DonanımHaber
Can Oramed Pharmaceuticals Inc. stock withstand economic slowdownProduct Launch & Daily Stock Trend Watchlist - DonanımHaber
Can Oramed Pharmaceuticals Inc. (OJU1) stock double in coming yearsQuarterly Portfolio Summary & Verified High Yield Trade Plans - DonanımHaber
Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
Oramed Pharmaceuticals Earnings Notes - Trefis
How strong dollar benefits Oramed Pharmaceuticals Inc. (OJU1) stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - Newser
Why Oramed Pharmaceuticals Inc. stock appeals to analystsJobs Report & Free AI Powered Buy and Sell Recommendations - Newser
Will Oramed Pharmaceuticals Inc. stock gain from strong economyJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - Newser
Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growthRate Hike & Community Verified Trade Signals - Newser
How Oramed Pharmaceuticals Inc. (OJU1) stock correlates with oil markets2025 Short Interest & Stock Market Timing Techniques - Newser
How Oramed Pharmaceuticals Inc. (OJU1) stock valuation compares with sectorJuly 2025 Final Week & Weekly Setup with High ROI Potential - Newser
Is Oramed Pharmaceuticals Inc. (OJU1) stock a buy on weakness2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
Is Oramed Pharmaceuticals Inc a good long term investmentSector Performance Review & High Yield Trading Growth - earlytimes.in
ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted - Yahoo Finance
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):